NEWS
Study Urges Caution on Source of Unrelated Donor Stem Cell Transplants
The first randomized trial comparing bone marrow and peripheral blood stem cells (PBSCs) as sources for hematopoietic stem cell transplants from unrelated donors suggests that caution may be needed when using PBSCs from unrelated donors to treat leukemia or related blood disorders. The results were published October 18 in the New England Journal of Medicine. Read more > >
Study Looks at Terminal Cancer Patients' Expectations of Chemotherapy
Majority of patients with metastatic lung or colorectal cancer believed chemotherapy could cure their diseaseImatinib May Help Treat Aggressive Lymphoma
Clinical trial will test drug in patients with anaplastic large cell lymphomaResearchers Identify Possible Biomarker for Early-Stage Lung Cancer
Variant form of the Ciz1 protein could be measured to screen at-risk individuals noninvasivelyIn Mice, Combining Cancer Vaccine and Low-Dose Anti-Angiogenesis Drug Shows Promise against Breast Cancer
"Normalizing" tumor blood vessels appears to improve vaccine's efficacy
COMMENTARY
Building Momentum: NCI's Center for Global Health
Dr. Ted Trimble, director of NCI's Center for Global Health, discusses how the new center will work to reduce the global burden of cancer. 
A Conversation with Dr. Patrick Loehrer about Improving Cancer Care in Kenya
The director of the Indiana University Melvin and Bren Simon Cancer Center describes a collaborative effort to establish a cancer program and treatment center at the Moi University School of Medicine in Eldoret, Kenya.
IN DEPTH
Tackling the Complexity of Genes and Environments in Cancer
Scientists are just beginning to study gene-environment interactions in common diseases
Featured Clinical Trial: Safety of Stem Cell Transplants for HIV-Positive Cancer Patients
Can HIV-positive cancer patients tolerate hematopoietic stem cell transplantation?
UPDATES
Notes
- In Memoriam: Dr. E. Donnall Thomas
- Board of Scientific Advisors to Meet November 5
- Cyber-Seminar: Adapting and Using Evidence-Based Programs with Community Partners
A MESSAGE TO READERS
Cancer Resources for Those Affected by Hurricane Sandy
Information is available to help cancer patients, physicians, and researchers who are in areas affected by recent storms.
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
